NKT cells - new players in CAR cell immunotherapy?
Low levels of peripheral blood natural killer T (NKT) cells in cancer patients and a favorable outcome associated with a high number of tumor-infiltrating NKT cells demonstrated in several studies indicated the important role of these immune cells in the antitumor response. With effective antitumor...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
06 September 2018
|
| In: |
European journal of haematology
Year: 2018, Volume: 101, Issue: 6, Pages: 750-757 |
| ISSN: | 1600-0609 |
| DOI: | 10.1111/ejh.13170 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1111/ejh.13170 Verlag: https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13170 
|
| Author Notes: | Katharina Kriegsmann, Mark Kriegsmann, Michael von Bergwelt‐Baildon, Martin Cremer, Mathias Witzens‐Harig |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1680561189 | ||
| 003 | DE-627 | ||
| 005 | 20220817012435.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191029s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ejh.13170 |2 doi | |
| 035 | |a (DE-627)1680561189 | ||
| 035 | |a (DE-599)KXP1680561189 | ||
| 035 | |a (OCoLC)1341249341 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kriegsmann, Katharina |d 1986- |e VerfasserIn |0 (DE-588)1049422449 |0 (DE-627)781924006 |0 (DE-576)40339774X |4 aut | |
| 245 | 1 | 0 | |a NKT cells - new players in CAR cell immunotherapy? |c Katharina Kriegsmann, Mark Kriegsmann, Michael von Bergwelt‐Baildon, Martin Cremer, Mathias Witzens‐Harig |
| 264 | 1 | |c 06 September 2018 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.10.2019 | ||
| 520 | |a Low levels of peripheral blood natural killer T (NKT) cells in cancer patients and a favorable outcome associated with a high number of tumor-infiltrating NKT cells demonstrated in several studies indicated the important role of these immune cells in the antitumor response. With effective antitumor immunity via direct tumor lysis, cytokine modulation of effector cells and regulation of immunosuppressive cells, type I NKT cells display interesting features/properties for the rapidly developing chimeric antigen receptor (CAR) technology. Due to their restriction to the monomorphic HLA-like molecule CD1d, but not to the polymorphic human leukocyte antigen (HLA), NKT CAR cells show potential for enabling autologous and allogeneic/off-the-shelf cancer immunotherapy. Promising results were obtained in preclinical NKT CAR cell studies, but clinical trials have not yet been conducted. In this review, we summarize the biological features of NKT cells, their role in antitumor immunity and recent advances in the development of NKT CAR cells. | ||
| 650 | 4 | |a antitumor immunity | |
| 650 | 4 | |a chimeric antigen receptor (CAR) | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a Natural killer T (NKT) cells | |
| 700 | 1 | |a Kriegsmann, Mark |d 1987- |e VerfasserIn |0 (DE-588)103740324X |0 (DE-627)755668782 |0 (DE-576)39141870X |4 aut | |
| 700 | 1 | |a Bergwelt‐Baildon, Michael von |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cremer, Martin |e VerfasserIn |0 (DE-588)1084363852 |0 (DE-627)848800796 |0 (DE-576)456316078 |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of haematology |d Oxford : Wiley-Blackwell, 1987 |g 101(2018), 6, Seite 750-757 |h Online-Ressource |w (DE-627)320983463 |w (DE-600)2027114-1 |w (DE-576)093888864 |x 1600-0609 |7 nnas |a NKT cells - new players in CAR cell immunotherapy? |
| 773 | 1 | 8 | |g volume:101 |g year:2018 |g number:6 |g pages:750-757 |g extent:8 |a NKT cells - new players in CAR cell immunotherapy? |
| 856 | 4 | 0 | |u https://doi.org/10.1111/ejh.13170 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13170 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191029 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 5 |y j | ||
| 998 | |g 1084363852 |a Cremer, Martin |m 1084363852:Cremer, Martin |d 910000 |d 910100 |e 910000PC1084363852 |e 910100PC1084363852 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 103740324X |a Kriegsmann, Mark |m 103740324X:Kriegsmann, Mark |d 910000 |d 912000 |e 910000PK103740324X |e 912000PK103740324X |k 0/910000/ |k 1/910000/912000/ |p 2 | ||
| 998 | |g 1049422449 |a Kriegsmann, Katharina |m 1049422449:Kriegsmann, Katharina |d 910000 |d 910100 |e 910000PK1049422449 |e 910100PK1049422449 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1680561189 |e 3530856037 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Katharina Kriegsmann, Mark Kriegsmann, Michael von Bergwelt‐Baildon, Martin Cremer, Mathias Witzens‐Harig"]},"recId":"1680561189","id":{"doi":["10.1111/ejh.13170"],"eki":["1680561189"]},"relHost":[{"id":{"zdb":["2027114-1"],"eki":["320983463"],"issn":["1600-0609"],"doi":["10.1111/(ISSN)1600-0609"]},"recId":"320983463","pubHistory":["38.1987 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"part":{"year":"2018","text":"101(2018), 6, Seite 750-757","pages":"750-757","extent":"8","volume":"101","issue":"6"},"title":[{"title":"European journal of haematology","title_sort":"European journal of haematology"}],"note":["Gesehen am 08.05.09"],"origin":[{"publisher":"Wiley-Blackwell ; Munksgaard ; Blackwell","dateIssuedKey":"1987","publisherPlace":"Oxford ; Copenhagen ; Oxford [u.a.]","dateIssuedDisp":"1987-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"NKT cells - new players in CAR cell immunotherapy?European journal of haematology"}],"person":[{"family":"Kriegsmann","display":"Kriegsmann, Katharina","role":"aut","given":"Katharina"},{"role":"aut","given":"Mark","family":"Kriegsmann","display":"Kriegsmann, Mark"},{"family":"Bergwelt‐Baildon","display":"Bergwelt‐Baildon, Michael von","given":"Michael von","role":"aut"},{"family":"Cremer","display":"Cremer, Martin","role":"aut","given":"Martin"},{"given":"Mathias","role":"aut","display":"Witzens-Harig, Mathias","family":"Witzens-Harig"}],"note":["Gesehen am 29.10.2019"],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"06 September 2018"}],"title":[{"title_sort":"NKT cells - new players in CAR cell immunotherapy?","title":"NKT cells - new players in CAR cell immunotherapy?"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} | ||
| SRT | |a KRIEGSMANNNKTCELLSNE0620 | ||